Precision Business Insights
Portfolio

 

Research Reports

Wearable Insulin Devices Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Wearable Insulin Devices Market

 

By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Wearable Insulin Devices Market

Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

 

Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

 

Market Scope: Wearable Insulin Devices Market

Wearable insulin devices market is segmented based on the product type, age group, and distribution channel

Based on the product type, the market is segmented into the following:

  • Patches
  • Pods

Based on the age group, the market is segmented into the following:

  • Adults
  • Pediatrics

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Regional Analysis:  Wearable Insulin Devices Market

Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

 

Competition Assessment: Wearable Insulin Devices Market

Some of the players in the global wearable insulin devices market include:

  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

 

Notable Market Developments: Wearable Insulin Devices Market

  • In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Contact SalesTOLL FREE: +1-866-598-1553